Influence of Renal Function on Mortality and Ventricular Arrhythmias in Patients Undergoing First Implantable Cardioverter‐Defibrillator Generator Replacement

Impaired renal function is associated with increased mortality among patients with implantable cardioverter‐defibrillators (ICDs). The relationship between renal function at time of ICD generator replacement and subsequent appropriate ICD therapies is not known.

[1]  Paul L Hess,et al.  Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  Talicia A Tarver.  HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION , 2014 .

[3]  M. Josephson,et al.  Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR. , 2014, Heart rhythm.

[4]  C. Ching,et al.  Clinical markers of organ dysfunction associated with increased 1-year mortality post-implantable cardioverter defibrillator implantation. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  Sharon-Lise Normand,et al.  Characteristics and Outcomes of Patients Receiving New and Replacement Implantable Cardioverter-Defibrillators: Results From the NCDR , 2013, Circulation. Cardiovascular quality and outcomes.

[6]  R. Fimmers,et al.  Kidney Dysfunction and Deterioration of Ejection Fraction Pose Independent Risk Factors for Mortality in Implantable Cardioverter‐Defibrillator Recipients for Primary Prevention , 2012, Clinical cardiology.

[7]  P. Zimetbaum,et al.  Time for a change--a new approach to ICD replacement. , 2012, The New England journal of medicine.

[8]  J. Piccini,et al.  Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[9]  H. Halperin,et al.  End‐Stage Renal Disease Predicts Complications in Pacemaker and ICD Implants , 2011, Journal of cardiovascular electrophysiology.

[10]  R. Fimmers,et al.  An Impaired Renal Function: A Predictor of Ventricular Arrhythmias and Mortality in Patients with Nonischemic Cardiomyopathy and Heart Failure , 2011, Pacing and clinical electrophysiology : PACE.

[11]  Eugene Crystal,et al.  Predictors of Short-Term Complications After Implantable Cardioverter-Defibrillator Replacement: Results From the Ontario ICD Database , 2011, Circulation. Arrhythmia and electrophysiology.

[12]  V. Alla,et al.  Impact of Moderate to Severe Renal Impairment on Mortality and Appropriate Shocks in Patients with Implantable Cardioverter Defibrillators , 2010, Cardiology research and practice.

[13]  Jeroen J. Bax,et al.  Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy. , 2010, The American journal of cardiology.

[14]  Benjamin C. Culp,et al.  Effect of renal function on survival after implantable cardioverter defibrillator placement. , 2010, The American journal of cardiology.

[15]  R. Fimmers,et al.  An impaired renal function and advanced heart failure represent independent predictors of the incidence of malignant ventricular arrhythmias in patients with an implantable cardioverter/defibrillator for primary prevention. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[17]  R. Passman,et al.  NON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Sudden Cardiac Death and Dialysis Patients , 2008, Seminars in dialysis.

[18]  A. Atav,et al.  The Relationship Between Glomerular Filtration Rate and Survival in Patients Treated with an Implantable Cardioverter Defibrillator , 2008, Clinical cardiology.

[19]  A. Moss,et al.  Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. , 2008, Journal of the American College of Cardiology.

[20]  Michael R Gold,et al.  Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. , 2007, Journal of the American College of Cardiology.

[21]  M. Turakhia,et al.  Impact of Renal Function on Survival in Patients with Implantable Cardioverter‐Defibrillators , 2007, Pacing and clinical electrophysiology : PACE.

[22]  W. Maisel,et al.  Mortality Following Defibrillator Implantation in Patients with Renal Insufficiency , 2006, Journal of cardiovascular electrophysiology.

[23]  S. Saba,et al.  Renal insufficiency predicts the time to first appropriate defibrillator shock. , 2006, American heart journal.

[24]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[25]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[26]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[27]  J. Zaidan.  Implantable cardioverter-defibrillators. , 1999, Journal of cardiothoracic and vascular anesthesia.

[28]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[29]  D. Hodge,et al.  Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. , 2012, Heart rhythm.

[30]  鈴木 敦,et al.  Impact of renal dysfunction on appropriate therapy in implantable cardioverter defibrillator patients with non-ischaemic dilated cardiomyopathy , 2010 .